A shot offering protection against a common childhood disease was one of the 20th century’s major public health advances. For the author’s young sister, it came too late.
â Phase 1/2 Trial to Evaluate the Safety, Tolerability and Immunogenicity of Micron s Microneedle-Based Measles-Rubella Vaccine â
ATLANTA, July 13, 2021 /PRNewswire/ - Micron Biomedical, Inc. ( Micron or the Company ), a leader in dissolving, microneedle-based vaccine and drug delivery, today announced that it has initiated a Phase 1/2 clinical trial of its microneedle-based measles-rubella ( MR ) vaccine.
The trial will assess the safety, tolerability and immunogenicity of an MR vaccine delivered using Micron s technology, compared with delivery via standard subcutaneous injection, in adults and children. The Company-sponsored Phase 1/2 trial will be conducted at the Medical Research Council Unit The Gambia ( MRCG ) under the leadership of Ed Clarke, MB ChB PhD, Head of Infant Immunology at the London School of Hygiene and Tropical Medicine ( LSHTM ) in The Gambia.
Micron Biomedical Initiates First-Ever Microneedle Vaccine Clinical Trial in Children apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Division Director
Dr. Stephanie R. Bialek, MD, MPH, is the director of the Division of Viral Diseases in CDC’s National Center for Immunization and Respiratory Diseases (NCIRD), since 2020. Dr. Bialek, a captain in the United States Public Health Service, leads a division with 4 branches, 27 programs, and over 300 staff, fellows, and contractors.
During her career, Dr. Bialek has worked on a wide range of domestic and international public health programs. She joined CDC as an Epidemic Intelligence Service officer in 1999 and worked in the Division of Viral Hepatitis. After completing the practicum year of her residency in Preventive Medicine at the Georgia Department of Public Health in 2003, Dr. Bialek returned to the Division of Viral Hepatitis as a medical epidemiologist working on hepatitis B vaccine effectiveness and chronic hepatitis B and C.